TürkçeWhat Are the Symptoms of Advanced Prostate Cancer?
Advanced prostate cancer symptoms include a weakened urine stream, blood in the urine or semen, severe pain that does not improve with rest, especially in the lower back, hips, and spinal bones, unexplained weight loss, and numbness in the legs. When cancer cells penetrate the protective capsule of the prostate gland and spread into surrounding tissues, the lymphatic system, or the bloodstream, the body begins to produce these urgent warning signals. Unlike the silent nature of the early stages, these clinical findings that appear in advanced stages indicate that the disease has reached a systemic level. Proper evaluation of these symptoms without delay, taking appropriate steps, and preserving daily quality of life are of vital importance.
Why Are the Symptoms of Advanced Prostate Cancer Usually Detected in the Later Stages?
The nature of prostate cancer may involve a very slow and insidious progression compared to many other types of cancer. During the early stages, when the disease remains confined to the prostate gland, it usually causes no noticeable discomfort. Since tumor formations generally begin in the outer part of the prostate rather than the inner portions, they may not immediately compress the urethra, allowing individuals to continue their daily lives without noticing any changes. If routine health checkups are neglected or regular screening programs are not followed, the cells may continue multiplying silently for months or even years. This silent growth process may eventually result in the tumor penetrating the protective capsule surrounding the prostate or spreading microscopically into the lymphatic vessels. The disease usually begins producing obvious warning signs only after it starts damaging surrounding tissues or reaches distant organs such as the bones. Therefore, the onset of symptoms generally indicates that the disease has progressed beyond the boundaries of the prostate. Various factors, including lifestyle habits, genetic predisposition, and dietary patterns, are also believed to influence the rate of disease progression.
Which Urinary Tract Symptoms Are Seen in Advanced Prostate Cancer?
As the tumor increases in size and mechanically compresses the bladder neck and the urethra from the outside, the process of eliminating urine from the body becomes directly impaired. Urinary symptoms are among the leading problems that significantly reduce patients’ quality of daily life. The enlarging tissue may narrow the urinary passage, preventing complete bladder emptying or constantly stimulating the bladder muscles, thereby disrupting their storage capacity.
The main urinary problems that may occur include:
- Difficulty initiating urination
- Reduced urine flow rate
- Intermittent urination
- Frequent urination
- Waking up at night to urinate
- Urinary incontinence
These problems create a constant sensation of a full bladder and cause patients to spend extended periods in the bathroom. Initially, the bladder muscle must work much harder to push urine through the narrowed channel and may eventually become thickened and fatigued. The need to wake up frequently at night to urinate also creates a cycle that negatively affects daytime energy levels and overall psychological well-being.
Is Blood in the Urine or Semen a Symptom of Advanced Prostate Cancer?
As cancer cells multiply rapidly, they tend to form new networks of blood vessels to meet their increasing oxygen and nutritional demands. However, these newly formed vessels are much weaker, thinner-walled, and more fragile than normal blood vessels. Pressure exerted by the tumor on surrounding tissues and friction within the urinary tract can easily cause these delicate vessels to rupture. As a result, patients may notice blood in their urine or semen.
Possible findings associated with bleeding include:
- Pink-colored urine
- Red-colored urine
- Urine containing blood clots
- Rust-colored semen
- Bloody semen
This bleeding is not always severe and may sometimes remain microscopic, becoming apparent only during routine laboratory testing. However, when it becomes visible, particularly if blood clots are present, it may obstruct the urinary tract and lead to emergency situations such as acute urinary retention. The presence of blood in the urine or semen is an important warning sign indicating that medical evaluation should be expedited.
How Does Advanced Prostate Cancer Affect Sexual Function and the Pelvic Region?
The prostate gland is not only an essential part of the male reproductive system but is also located in close proximity to the complex network of nerves and blood vessels responsible for normal sexual function. These nerve bundles pass along both sides of the prostate before reaching the penis. When tumor cells extend beyond the prostate capsule and invade these nerve bundles, significant impairment of sexual function may occur. Achieving or maintaining an erection sufficient for sexual intercourse may become increasingly difficult.
In addition, invasion of the seminal ducts or seminal vesicles by the tumor may cause uncomfortable pain in the lower abdominal region, known as the pelvic area, during ejaculation. Pain and sexual dysfunction experienced during intercourse are among the indicators that the disease has anatomically spread into surrounding tissues. Since these changes can affect not only patients’ physical health but also their emotional well-being, careful management of the process is of great importance.
What Type of Pain Develops When Advanced Prostate Cancer Spreads to the Bones?
When the disease spreads far beyond the prostate gland through the bloodstream, the skeletal system becomes one of the most common sites where cancer cells settle. Once cancer cells reach the bone tissue, they disrupt the natural cycle of bone formation and breakdown, causing destruction within the affected area. This damage stimulates nerve endings and stretches the periosteum, resulting in persistent pain.
The main bones to which the disease may spread include:
- Spinal bones
- Pelvic bones
- Femur
- Rib cage
- Ribs
Pain caused by bone metastases generally differs from ordinary muscle pain. It typically does not improve with rest or changes in body position and often becomes more severe at night, presenting as a deep aching pain that may significantly restrict daily activities. If the cancer burden within the spine increases, weakened bones may collapse suddenly or compress the spinal cord, leading to severe pain radiating into the legs or causing numbness.
What Systemic and Internal Organ Symptoms May Be Seen in Advanced Prostate Cancer?
In addition to the bones, cancer cells may spread to internal organs in advanced-stage disease. Involvement of organs such as the lungs or liver indicates that the overall tumor burden within the body has increased substantially. Cancer tissue develops the ability to rapidly consume the body’s energy reserves and alter metabolism in its favor. This process creates the basis for systemic symptoms affecting the entire body rather than a single anatomical region.
Common systemic symptoms include:
- Loss of appetite
- Unexplained weight loss
- Profound fatigue
- Anemia
- Shortness of breath
- Abdominal pain
Patients may experience significant weight loss within a short period despite making no changes to their diet. Muscle wasting combined with severe anemia can cause extreme fatigue even during minimal daily activities. Symptoms such as persistent cough or digestive problems resulting from internal organ involvement reflect the overall impact of advanced disease on the body.
Which Clinical Examinations and Laboratory Tests Are Used to Diagnose Advanced Prostate Cancer?
The purpose of the clinical evaluation performed after symptoms develop is to confirm the presence of the disease and determine its extent. One of the first and most valuable examinations is the digital rectal examination. During this examination, the physician palpates the back surface of the prostate through the rectum to identify structural abnormalities. In advanced disease, the prostate may feel hard, irregular, rough, and lose its normal elasticity. However, physical examination alone cannot accurately determine the size of the tumor or how far it has spread.
Laboratory tests are used to support these findings. The Prostate-Specific Antigen (PSA) blood test is the most widely used marker. PSA levels that are significantly above the normal reference range indicate marked cellular activity within the prostate. To further clarify the diagnosis, additional calculations such as PSA density, obtained by dividing the total PSA level by the prostate volume, help distinguish benign prostatic enlargement from prostate cancer. These evaluations determine the need for advanced imaging studies.
Which Advanced Imaging Methods Are Used to Evaluate the Spread of Advanced Prostate Cancer?
When clinical suspicion becomes stronger, advanced radiological imaging techniques are used to create a detailed anatomical map of the disease. Multiparametric Magnetic Resonance Imaging (mpMRI) is a highly effective technology that demonstrates the internal structure of the prostate, the density of cancerous tissues, and the proximity of the tumor to surrounding structures with high resolution. This method enables precise assessment of the tumor’s relationship with the bladder, urethra, and seminal vesicles.
However, a more comprehensive examination may be necessary to determine whether the disease has spread throughout the body. At this stage, PSMA PET/CT imaging, also known as smart imaging, becomes important. Low-dose radioactive tracers that bind to a specific protein found on the surface of prostate cancer cells are used to scan the entire body.
The primary imaging targets include:
- Tumor foci within the prostate
- Regional lymph nodes
- Distant lymph nodes
- Bone tissue
- Internal organs
This technology provides physicians with a significant advantage by revealing even very small cancer cells that cannot be detected by standard CT scans or bone scintigraphy, allowing the true stage of the disease to be determined.
Which Modern Biopsy Techniques Confirm the Diagnosis of Advanced Prostate Cancer?
Once suspicious areas have been identified through imaging methods, a biopsy is performed to establish a definitive cellular diagnosis. Today, traditional random sampling techniques have largely been replaced by MRI-TRUS fusion biopsy technology, which is much more targeted. In this method, previously obtained detailed MRI images are superimposed on real-time ultrasound images during the biopsy using specialized computer software. As a result, the biopsy needle bypasses healthy prostate tissue and is directed precisely toward the suspicious lesions identified on MRI.
The biopsy procedure itself has also evolved to improve patient comfort and safety. Instead of the traditional transrectal approach, the transperineal technique performed through the skin is increasingly preferred.
The advantages of the transperineal approach include:
- More accurate targeting of suspicious lesions
- Easier access to the anterior regions of the prostate
- Reduced risk of infections originating from intestinal bacteria
- More comprehensive tissue mapping
The tissue samples obtained are examined under a microscope to determine the aggressiveness of the cancer cells. A high degree of aggressiveness is considered clinical evidence that the disease has a tendency to extend beyond its local boundaries.
Which Surgical Approaches May Be Preferred for Locally Advanced Prostate Cancer?
If the disease has extended beyond the prostate capsule but has not yet spread to distant bones or organs, it is classified as locally advanced prostate cancer. The primary treatment strategy at this stage is to remove as much tumor burden as possible from the body. During radical prostatectomy, the prostate gland, seminal vesicles, and surrounding lymph nodes considered to be at risk are removed as a single unit. Since the disease is already advanced, the surgical margins may be extended to ensure complete tumor removal.
Depending on the surgeon’s experience and the patient’s condition, surgery may be performed using open, laparoscopic, or robotic techniques. Robotic technology provides improved visualization by transmitting the surgeon’s hand movements with millimetric precision. It helps reduce blood loss, decrease postoperative pain, and shorten hospital stays. Because the cancer has spread beyond the prostate, preserving the nerves responsible for sexual function is not always possible; however, nerve-sparing techniques may still be attempted when anatomically appropriate. The ultimate goal is to maximize oncological safety.
How Are Radiotherapy and Hormone Therapy Applied in the Treatment of Advanced Prostate Cancer?
When surgery is considered too risky for locally advanced disease or when the patient’s general health is unsuitable for major surgery, combined non-surgical treatment strategies become the preferred approach. Additional therapies may also be required after surgery to eliminate microscopic cancer cells that may remain. During this process, radiotherapy and hormone therapy are frequently administered together.
Radiotherapy aims to damage the DNA of cancer cells and stop their proliferation by directing high-energy radiation precisely toward the prostate and high-risk lymph nodes. To enhance the effectiveness of radiation therapy, androgen deprivation therapy, commonly known as hormone therapy, is administered simultaneously.
The main effects of hormone therapy on the body include:
- Suppressing testosterone production
- Cutting off the tumor’s nutritional support
- Slowing the growth rate of cancer cells
- Enhancing the cellular destructive effect of radiotherapy
Prostate cancer cells require testosterone, the primary male hormone, to grow. Hormone therapy medications reduce testosterone levels to extremely low levels, effectively starving the tumor cells. This combined approach can make a substantial contribution to regional disease control and slowing disease progression.
How Is Drug Resistance Managed in Metastatic Advanced Prostate Cancer?
When the disease spreads to the bones or other organs, the focus of treatment shifts from local interventions to systemic therapies that affect the entire body. The cornerstone of metastatic disease treatment is hormone therapy aimed at eliminating testosterone. Initially, cancer cells often respond very well to this treatment. However, over months or years, they may adapt and learn to survive and proliferate even in a low-testosterone environment. This condition is clinically known as castration-resistant prostate cancer.
Once resistance develops, standard hormone injections may no longer be sufficient, and treatment is updated with newer targeted medications. More potent oral drugs that directly block receptors within cancer cells or inhibit hormone synthesis at the cellular level are added to therapy. When necessary, modern chemotherapy agents that disrupt the cellular skeleton responsible for cancer cell division are also used. These treatment transitions are carefully adjusted according to regular blood tests and imaging results to maintain disease control.
What Emergency Interventions Are Performed When Advanced Prostate Cancer Threatens the Kidneys?
When the tumor expands toward the base of the bladder or disease involving the lymph nodes compresses the ureters, the thin tubes carrying urine from the kidneys to the bladder, urine flow may become obstructed. The resulting backflow causes swelling of the kidneys and impairs their function. This condition, known as hydronephrosis, may lead to permanent kidney damage if not treated urgently.
Interventional procedures used to restore urine flow include:
- Placement of a ureteral stent via cystoscopy
- Insertion of a percutaneous nephrostomy catheter
- Placement of a urinary catheter
To bypass the obstruction, a thin flexible tube called a stent is generally inserted through the urinary tract and advanced into the kidney, creating an internal passage. However, when tumor compression is too severe to allow stent placement, nephrostomy tubes are inserted directly into the kidney through the lower back under local anesthesia to drain urine into an external collection bag. These interventions are critical for preserving kidney function and preventing life-threatening infections.
What Can Be Done to Preserve Quality of Life When Advanced Prostate Cancer Affects Bone Health?
Among the most destructive consequences of bone metastases are sudden fractures resulting from weakened bone tissue and persistent chronic pain. Preserving patients’ quality of life and maintaining their ability to perform daily activities independently are among the primary goals of treatment. Special bone-strengthening medications are administered to protect and reinforce the skeleton.
The primary medical goals for preserving bone health include:
- Slowing bone destruction
- Reducing fracture risk
- Relieving pain
- Maintaining mobility
These medications, which reduce bone destruction, are administered regularly as monthly injections to support the skeletal system. If severe pain is localized to a specific bone, low-dose radiotherapy directed to that area can provide excellent pain relief. In cases of widespread bone involvement, radioactive isotope therapies administered intravenously, which specifically target cancerous bone tissue and deliver radiation internally, may also be used. These approaches aim both to substantially reduce pain and to enable patients to continue their daily lives with greater comfort. Regardless of how advanced the disease has become, modern medicine often makes it possible to relieve symptoms and manage the condition more effectively through these comprehensive treatment strategies.
Frequently Asked Questions
